Atlas Trials

Tern Therapeutics, LLC

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Tern Therapeutics, LLC

RecordFirmDate
A First-in-Human, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of Gene Therapy With TTX-381 for the Ocular Manifestations Associated With Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease (NCT05791864)Tern Therapeutics, LLC2023-05-17

Track Tern Therapeutics, LLC automatically

Every clearance here is in the API, with alerts when new ones post.